Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nora Sziray is active.

Publication


Featured researches published by Nora Sziray.


Brain Research Bulletin | 2006

Pharmacological evaluation of the stress-induced social avoidance model of anxiety

Cs. Leveleki; Nora Sziray; György Lévay; B. Barsvári; K. Soproni; Éva Mikics; József Haller

We have shown earlier that mild electric shocks induce a lasting social avoidance in male rats. Here we investigated whether shock-induced social avoidance can be developed into a laboratory model of stress-induced anxiety. The putative new model would assess sub-chronic, stress-induced anxiety (as opposed to tests based on natural fear) in a heterologous context (as opposed to classical fear conditioning). A single exposure to mild electric shocks induced a robust social avoidance that lasted more than 5 days. Low doses of chlordiazepoxide (0.5, 1 mg/kg), diazepam (0.5, 1, 5 mg/kg), buspirone (0.3, 1 mg/kg), and fluoxetine (1, 3, 5 mg/kg) abolished this effect, whereas the anxiogenic compound m-chlorophenylpiperazine (0.5-3 mg/kg) induced social avoidance in unshocked rats. These effects were produced at doses that did not affect locomotion in the open field. Haloperidol (0.05, 0.1, 1, 5 mg/kg) influenced social avoidance at sedative doses only. The sensitivity of the model to anxiolytic agents was compromised at high (sedating) doses. Taken conjointly, these data show that shock-induced social avoidance can be used to assess the anxiolytic potential of compounds. In addition to predictive validity, the model appears to show construct and face validity as well: stress is among the etiological factors of, whereas social avoidance simulates the social deficits seen in, a variety of anxiety disorders. The model may be used to study the effects of anxiolytics on sub-chronic states of stress-induced anxiety.


Brain Research Bulletin | 2007

Mechanisms underlying the long-term behavioral effects of traumatic experience in rats: the role of serotonin/noradrenaline balance and NMDA receptors.

Nora Sziray; Cs. Leveleki; György Lévay; Bernadett Marko; Laszlo Gabor Harsing; Éva Mikics; B. Barsy; József Haller

Traumatic stressors induce long-lasting changes in behavior. It is believed that all three glutamatergic, serotonergic and noradrenergic neurotransmission play a role in the development of such behavioral changes, but their relative importance and relationship is poorly understood. We have shown previously that a single exposure of rats to electric shocks induces social avoidance for about 10 days. Here we assessed social avoidance 24 h after shock exposure in rats with chemically lesioned serotonergic and noradrenergic neurons. The effects of the NMDA receptor blocker MK-801 were also studied. When the serotonin/noradrenaline balance was shifted towards serotonergic dominance via chemical lesions, the behavioral dysfunction was markedly attenuated. The disruption of serotonergic neurotransmission (that lead to noradrenergic dominance) significantly increased the behavioral deficit. Shock responding was not secondary to lesion-induced differences in social behavior. Noteworthy, the brain noradrenaline/serotonin ratio correlated negatively with shock-induced social avoidance, suggesting that the ratio rather than absolute levels are important in this respect. In line with this assumption, double lesions had minor effects on social avoidance, suggesting that these monoaminergic systems modulate, but do not mediate the behavioral deficit. The blockade of NMDA receptors abolished the development of stress-induced social avoidance both when applied before shocks and when applied before behavioral testing. We confirmed that the long-term behavioral effects of traumatic experience result from glutamatergic activation, the effects of which are mediated by NMDA receptors. The development of the behavioral deficit is modulated by the balance between serotonergic and noradrenergic neurotransmission, possibly via effects on shock-induced glutamatergic activation.


Behavioural Brain Research | 2010

Effects of single and simultaneous lesions of serotonergic and noradrenergic pathways on open-space and bright-space anxiety-like behavior in two animal models.

Nora Sziray; Zsófia Kuki; Katalin Nagy; Bernadett Marko; Hajnalka Kompagne; György Lévay

The objective of the present study is to investigate the effects of single and simultaneous lesions of the noradrenergic and serotonergic pathways (NA-X, 5-HT-X and XX, respectively) by intracerebroventricular administration of selective neurotoxins N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine-HCl (DSP-4) and 5,7-dihydroxytryptamine (5,7-DHT) on anxiety-like behavior in rats. To evaluate the effects of the various lesions, animals were tested in elevated plus-maze (EPM) and light-dark (LD) paradigms. In EPM, single lesions produced strong, statistically significant increase (p<0.001) of both time spent in the open arms (OT) and number of entries into the open arms (OE) compared to sham-lesioned animals. Simultaneous lesion further strengthened this anxiolytic effect causing an approximate 500% elevation of OT compared to sham-lesioned animals. In LD, 5-HT lesion caused a significant (p<0.05) increase in both light movement time and light horizontal activity parameters compared to intact, sham, and NA-lesioned groups. Neither of the lesions caused any change in the spontaneous locomotor activity of the animals up to 15min as measured in activity meter. These findings suggest that single and simultaneous lesions of 5-HT- and NA-pathways modify anxiety-related state of experimental animals to different extents and these modifications alter the behavior of animals differently in the two models used: NA-X and 5-HT-X reduce open space anxiety-like behavior and XX further strengthens this effect in the EPM, while only 5-HT-X is resulting in reduced bright-space anxiety-like behavior leaving the performance of NA-X and XX animals unchanged.


Annals of General Psychiatry | 2006

Changes in learning and memory after single and simultaneous lesion of the serotonergic and noradrenergic systems in the rat

Nora Sziray; Zsófia Kuki; Gábor Kapus; Bernadett Marko; Istvan Gacsalyi; György Lévay

Background Noradrenergic (NA) and serotonergic (5-HT) pathways play an inevitable role in several crucial central nervous system functions such as learning and memory, sleep, food-consumption and mood. Slight changes in the state of equilibrium of these neurotransmitters can lead to the development of severe psychiatric states. Dysfunction of these systems may be responsible for the considerable deficits of memory and learning processes occuring in mood and anxiety disorders. Nevertheless the exact mechanism by which these monoamines influence these processes are not yet fully understood. The way of interaction of these two systems between each other and with other neurotransmitters and neuromodulators is still an interesting field of CNS-research.


Pharmacology, Biochemistry and Behavior | 2003

The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.

Laszlo Gabor Harsing; Istvan Gacsalyi; Geza Szabo; Eva Schmidt; Nora Sziray; Claude Sebban; Brigitte Tesolin-Decros; Péter Mátyus; Andras Egyed; Michael Spedding; György Lévay


Critical Reviews in Neurobiology | 2004

AMPA receptor blockade potentiates the stimulatory effect of L-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation.

Zsolt Juranyi; Nora Sziray; Bernadett Marko; György Lévay; Laszlo Gabor Harsing


Brain Research Bulletin | 2007

Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism

Katalin Megyeri; Bernadett Marko; Nora Sziray; Istvan Gacsalyi; Zsolt Juranyi; György Lévay; Laszlo Gabor Harsing


Archive | 2005

3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders

Balázs Volk; Jozsef Barkoczy; Gyula Simig; Tibor Mezei; Dezsofi Rita Kapillerne; Endréné Flórián; Istvan Gacsalyi; Katalin Pallagi; Gabor Gigler; Gyoergy Levay; Krisztina Moricz; Csilla Leveleki; Nora Sziray; Gábor Szénási; Andras Egyed; Laszlo Gabor Harsing


Archive | 2008

New benzofuran derivatives as selective 5ht6 receptor inhibitors and process for their preparation

Endre Rivo; Ibolya Prauda; Jozsef Reiter; Jozsef Barkoczy; Istvan Gacsalyi; Hajnalka Kompagne; Nora Sziray; Katalin Pallagi; Andras Egyed; Endre Hegedüs; György Lévay; Laszlo Gabor Harsing


Archive | 2005

Piperazine derivatives of alkyl oxindoles

Balázs Volk; Jozsef Barkoczy; Gyula Simig; Tibor Mezei; Dezsofi Rita Kapillerne; Istvan Gacsalyi; Katalin Pallagi; Gabor Gigler; Gyoergy Levay; Krisztina Moricz; Csilla Leveleki; Nora Sziray; Gábor Szénási; Andras Egyed; Laszlo Gabor Harsing

Collaboration


Dive into the Nora Sziray's collaboration.

Researchain Logo
Decentralizing Knowledge